RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Biograph Vision (PET / KT-skaner)

Product
Developers: Siemens Healthineers (ранее Siemens Healthcare)
Last Release Date: October, 2018
Branches: Pharmaceutics, medicine, health care
Technology: PACS

2018: Announcement of the version of RT Pro

On October 18, 2018 submitted to Siemens Healthineers the new version of Biograph Vision RT Pro – the equipment for a positron and issue or computer tomography (PET/KT) and planning by radiation therapy.

A system is equipped with the new detector which provides higher level of permission and sensitivity that will allow to estimate more precisely a progression of a disease and if necessary as soon as possible to correct treatment. The wide window a dimeter of 78 cm allows to place special devices for positioning of the patient which conform to the last requirements for quality control of a computer tomography.

PET / KT-skaner Biograph Vision RT Pro

Reconstruction of HD FOV Pro allows the user to receive the image of high resolution visualizing a complete circuit of the patient. Biograph Vision RT Pro has several mechanisms for leveling of effect of respiratory movements on the final image, including the mechanism of synchronization of PET/KT with breath; program of the time maximum intensity (t-MIP) of projections; the mechanism of synchronization of the phases AverageCT for automatic reduction of shifts when carrying out consecutive researches PET and KT; and also the mechanism of synchronization of KT-scanning at patients with slow breath.

Additional opportunities for planning of treatment include an iterative algorithm of iMAR for minimization of influence of different metal artifacts on KT which can be also used at reconstruction of PET; KT with two radiation sources; and the FAST Dual Energy Results application which facilitates input of monoenergetic data sets in the system of archiving and transfer of images (PACS).

Siemens Healthineers hopes that it new systems will help to personalize a research and treatment of patients with malignant diseases and to improve results of radiation therapy.[1]

Notes